This topic contains a solution. Click here to go to the answer

Author Question: Shrinking in height due to osteoporosis happens quickly and with sharp, jabbing pains in the spinal ... (Read 81 times)

soccerdreamer_17

  • Hero Member
  • *****
  • Posts: 552
Shrinking in height due to osteoporosis happens quickly and with sharp, jabbing pains in the spinal column.
 a. True
  b. False
  Indicate whether the statement is true or false

Question 2

Persons using potassium-sparing diuretics should be cautioned about consuming:
 
 a. salt substitutes.
  b. herbs and spices.
  c. soft drinks.
  d. dairy foods.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

duke02

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

False

Answer to Question 2

a




soccerdreamer_17

  • Member
  • Posts: 552
Reply 2 on: Aug 20, 2018
Thanks for the timely response, appreciate it


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Normal urine is sterile. It contains fluids, salts, and waste products. It is free of bacteria, viruses, and fungi.

Did you know?

There are over 65,000 known species of protozoa. About 10,000 species are parasitic.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library